Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
First-line Rituximab + CVP + interferon alfa-2b in untreated follicular lymphoma (phase II)
2005-004761-42Phase 2Completed
- Sponsor
- Fundación Leucemia y Linfoma
- Start
- Dec 2005
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of rituximab in follicular lymphoma (FL), sponsored by Fundación Leucemia y Linfoma. Primary endpoint: Progression-free survival. Started Dec 2005; status: completed.
02
Drugs
rituximab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on 2005-004761-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004761-42.